Cargando…
Identification of a key candidate gene-phenotype network mediated by glycyrrhizic acid using pharmacogenomic analysis
Glycyrrhizic acid (GA) is primarily used as an anti-inflammatory agent in cases of chronic hepatitis. However, its underlying mechanisms in diverse biological processes and its reported benefits are yet to be fully elucidated. In the current study, an analytical method based on pharmacogenomics was...
Autores principales: | Wang, Shiqun, Li, Lu, Shi, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691250/ https://www.ncbi.nlm.nih.gov/pubmed/31322195 http://dx.doi.org/10.3892/mmr.2019.10494 |
Ejemplares similares
-
Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid
por: Wang, Wei, et al.
Publicado: (2013) -
Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid
por: Ni, Qingqiang, et al.
Publicado: (2022) -
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19
por: Sun, Zhong, et al.
Publicado: (2021) -
Extraction of Glycyrrhizic Acid and Glabridin from Licorice
por: Tian, Minglei, et al.
Publicado: (2008) -
Glycyrrhizic acid derivatives as Dengue virus inhibitors
por: Baltina, Lidia A., et al.
Publicado: (2019)